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S U M M A R Y
Objective: The objective of this study was to assess the impact of a multidimensional infection control
approach for the reduction of catheter-associated urinary tract infection (CAUTI) in an adult intensive
care unit (ICU) of a hospital member of the International Nosocomial Infection Control Consortium
(INICC) in Lebanon.
Methods: A before–after prospective active surveillance study was carried out to determine rates of
CAUTI in 1506 ICU patients, hospitalized during 10 291 bed-days. The study period was divided into two
phases: phase 1 (baseline) and phase 2 (intervention). During phase 1, surveillance was performed
applying the deﬁnitions of the US Centers for Disease Control and Prevention National Healthcare Safety
Network (CDC/NHSN). In phase 2, we adopted a multidimensional approach that included: (1) a bundle
of infection control interventions, (2) education, (3) surveillance of CAUTI rates, (4) feedback on CAUTI
rates, (5) process surveillance, and (6) performance feedback. We used random effects Poisson regression
to account for clustering of CAUTI rates across time-periods.
Results: We recorded a total of 9829 urinary catheter-days: 306 in phase 1 and 9523 in phase 2. The rate
of CAUTI was 13.07 per 1000 urinary catheter-days in phase 1, and was decreased by 83% in phase 2 to
2.21 per 1000 urinary catheter-days (risk ratio 0.17; 95% conﬁdence interval 0.06–0.5; p = 0.0002).
Conclusions: Our multidimensional approach was associated with a signiﬁcant reduction in the CAUTI
rate.
 2013 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Catheter-associated urinary tract infections (CAUTI) have been
described in the scientiﬁc literature as one of the most common
device-associated healthcare-associated infections (DA-HAI) de-
veloped by patients hospitalized in the intensive care unit (ICU).
CAUTI acquired by critically ill patients has been associated with
prolonged hospital length of stay (LOS), bacterial resistance,
morbidity, and increased healthcare costs.1,2 More recently,
different published studies have shown divergence in terms of
its association with excess mortality, which may be the result of
confounding by unmeasured variables, i.e., lack of control for
lurking factors or hidden variables during the study, such as septic
shock, multiple organ failure, and ICU admission, receipt of* Corresponding author. Tel.: +54 11 4861 5826.
E-mail address: victor_rosenthal@inicc.org (V.D. Rosenthal).
URL: http://www.inicc.org
1201-9712/$36.00 – see front matter  2013 Published by Elsevier Ltd on behalf of In
http://dx.doi.org/10.1016/j.ijid.2013.01.020mechanical ventilation during the ﬁrst 48 h of ICU stay, use of
antibiotics, and extra-urinary sepsis.3–5
DA-HAI rates in the ICUs of countries with limited resources are
3- to 5-times higher than rates in the ICUs of high-income
countries, as reported from hospitals of the International
Nosocomial Infection Control Consortium (INICC).6
To our knowledge, the considerable inﬂuence exerted by the
socioeconomic level of a country and the type of hospital in DA-
HAIs in developing countries has only been assessed in two
studies.7,8With regard to the socioeconomic level of the country, in
a study conducted in pediatric ICUs it was shown that lower-
middle-income countries had higher CAUTI rates than low-income
countries or upper-middle-income countries (5.9 vs. 0.6 CAUTIs
per 1000 urinary catheter-days).8
On the other hand, it has been shown in different studies, most
from developed countries, that implementing infection control
programs and practice bundles is associated with a reduction in the
incidence density of CAUTI; these include hand hygiene, training
on care, maintenance, alternatives to indwelling catheters;9ternational Society for Infectious Diseases.
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management, and removal; inserting urinary catheters only when
needed; removing them when not necessary;10 maintaining
unobstructed urine ﬂow, among other interventions; and simulta-
neously, outcome surveillance of CAUTI rates and their conse-
quences, process surveillance, feedback on CAUTI rates, and
feedback on healthcare worker (HCW) performance.11
There is a pressing need for the implementation of prevention
strategies and programs in the developing world.12 We imple-
mented a multidimensional infection control approach in an adult
ICU of a hospital in Lebanon with the aim of reducing these high
CAUTI rates. This approach included speciﬁc interventions for
CAUTI prevention, such as a practice bundle, education, outcome
surveillance, process surveillance, and feedback of CAUTI rates, as
well as performance feedback for infection control practices. The
implementation of the INICC multidimensional approach for CAUTI
prevention is based on the recommendations and guidelines
published by the Society for Health Care Epidemiology of America
(SHEA) and the Infectious Diseases Society of America (IDSA) in
2008.13
This study is the ﬁrst to analyze the particular effect of this
multidimensional preventive strategy on CAUTI rates in the adult
ICU setting of a Lebanese hospital. The study was carried out from
November 2007 to March 2012.
2. Patients and methods
2.1. Setting and study design
This active, prospective outcome and process surveillance
before–after study was conducted from November 2007 to March
2012 in a medical–surgical adult ICU of the American University of
Beirut Medical Center (AUBMC), a tertiary care university hospital
in Lebanon and member of the INICC. The participating ICU has an
infection control team comprised of infection control profes-
sionals, and a medical doctor with a formal education and
background in infectious diseases. The nurse to patient ratio in
the ICU during the study period was 1:1–2.
The INICC headquarters team in Buenos Aires provided
infection control teams with centralized education, data analysis,
and coordination functions.
The Institutional Review Board of the hospital approved the
study protocol.
2.2. Intervention period and the goal of the INICC (phase 2)
The purpose of this INICC study was to achieve the highest
possible reduction in the rate of CAUTI in the participating ICU. The
intervention period (phase 2) was initiated after 3 months of
participation in the INICC outcome and process surveillance
program, and amounted to 50 months.
The INICC multidimensional infection control approach has
been described in a previous article,14 and includes the following
elements. First, the implementation of an infection prevention
bundle based on the guidelines published by the SHEA and the
IDSA, as modiﬁed by Lo et al.,13 which provide evidence-based
recommendations and cost-effective infection control measures
that can be feasibly adapted to the ICU setting in developing
countries. Second, the education of HCWs about infection
prevention measures. Third, CAUTI outcome surveillance by
applying the deﬁnitions for CAUTI developed by the US Centers
for Disease Control and Prevention National Healthcare Safety
Network (CDC/NHSN).15,16 Fourth, CAUTI process surveillance to
monitor compliance with easily measurable infection control
measures, including hand hygiene performance according to the
recommendations of the World Health Organization’s FiveMoments.17 Fifth, feedback on CAUTI rates routinely provided to
HCWs of the ICU. Sixth, performance feedback on process
surveillance, which was provided particularly by reviewing and
discussing chart results at monthly infection control meetings.
2.3. Deﬁnition of CAUTI
For the diagnosis of CAUTI, the patient had to meet one of two
criteria. The ﬁrst criterion was satisﬁed when a patient with a
urinary catheter had one or more of the following symptoms with
no other recognized cause: fever (temperature 38 8C), urgency,
and suprapubic tenderness; the urine culture was positive for 105
colony-forming units (CFU) per ml or more, with no more than
two microorganisms isolated. The second criterion was satisﬁed
when a patient with a urinary catheter had at least two of the
following criteria with no other recognized cause: positive
dipstick analysis for leukocyte esterase or nitrate and pyuria
(10 leukocytes/ml).15
2.4. Statistical methods
Characteristics of the patients in the participating ICUs recorded
at baseline and during the last 3 months of the intervention period
were compared using Fisher’s exact test for dichotomous variables
and the unmatched Student’s t-test for continuous variables. 95%
Conﬁdence intervals (CI) were calculated using VCStat (Castiglia).
Relative risk (RR) ratios with 95% CI were calculated for
comparisons of rates of CAUTI using Epi Info v.6. p-Values of
<0.05 by two-sided tests were considered signiﬁcant.
Further, we used Poisson regression to compare the rates of
CAUTI at baseline and during the-follow up period divided into 9–
24-month periods; we compared the CAUTI rates in each period
with the CAUTI rate at baseline. We used random effects Poisson
regression to account for clustering of CAUTI rates across time-
periods. These models were estimated using Stata 11.0.
3. Results
During the whole study period, a total of 1506 patients were
hospitalized during 10 291 bed-days in one ICU, amounting to
9829 urinary catheter-days.
Patient characteristics, including age, gender, device use ratio,
surgical stay, cancer, endocrine diseases, and abdominal surgery
conditions were similar during the two study phases (Table 1).
With regard to compliance rates, during phase 2, hand hygiene
compliance remained high and was similar during the two phases.
Similarly, compliance rates with the correct position of the urinary
catheter (over thigh) and collection bag hanging were 100% in both
phases (Table 1).
Regarding CAUTI rates, during phase 1 (baseline period), there
were 306 documented urinary catheter-days. There were four
CAUTIs, for an overall baseline rate of 13.07 CAUTIs per 1000
urinary catheter-days. The urinary catheter use mean was 0.96. In
phase 2, merging all data of the intervention period, after the
implementation of the multidimensional infection control pro-
gram, there were 9523 urinary catheter-days. There were 21
CAUTIs for an incidence density of 2.21 per 1000 urinary catheter-
days. The urinary catheter use mean was 0.96 as well. These results
showed a CAUTI rate reduction of 83% from baseline (13.07 to 2.21
CAUTIs per 1000 urinary catheter-days; RR 0.17, 95% CI 0.06–0.5;
p = 0.0002). The urinary catheter use mean was very similar in the
two periods (p = 0.983).
When using Poisson regression to compare the rates of CAUTI in
the two phases, divided into 9–12-month periods during the ﬁrst
year, we found a progressive reduction in the incidence of CAUTI,
which was decreased by 72% during the third year (Table 2).
Table 1
Characteristics of patients, hand hygiene compliance, and urinary catheter care in phase 1 (baseline period) and phase 2 (intervention period) of the study
Patient characteristics Baseline Intervention RRa 95% CI p- Value
Number of patients 35 1471 - - -
Study period, months 3 50 - - -
Urinary catheter duration, mean  SD 8.74  12.3 6.5  6.5 - - 0.288
Age, years, mean  SD 67.91  17.7 62.7  19.64 - - 0.126
Male, n (%) 20 (57%) 898 (61%) 1.07 0.69–1.66 0.770
Female, n (%) 15 (43%) 572 (39%)
Surgical stay, n (%) 11 (31%) 510 (36%) 1.13 0.62–2.05 0.6864
Abdominal surgery, n (%) 1 (3%) 73 (5%) 1.74 0.24–12.51 0.5777
Cancer, n (%) 3 (9%) 150 (10%) 1.19 0.38–3.73 0.7646
Endocrine diseases, n (%) 4 (11%) 118 (8%) 0.70 0.26–1.91 0.4866
Hand hygiene compliance, n/n (%) 134/139 (96%) 2074/2233 (93%) 0.96 0.81–1.15 0.6761
Compliance with urinary catheter on thigh, n/n (%) 268/268 (100%) 7406/7406 (100%) 1.0 0.89–1.13 1.0
Compliance with urinary catheter collection bag hanging, n/n (%) 268/268 (100%) 7406/7406 (100%) 1.0 0.89–1.13 1.0
CI, conﬁdence interval; RR, rate ratio; SD, standard deviation.
a For hand hygiene the relative risks rather than rate ratios are calculated.
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The burden of CAUTIs in critically ill patients has been widely
addressed in the scientiﬁc literature worldwide. CAUTIs have been
related to prolonged hospital LOS, bacterial resistance, morbidity,
and increased healthcare costs.2
The incidence of CAUTI is frequently underestimated in
hospitals from resource-limited countries, as in many cases basic
infection control programs cannot be systematically implemented.
If compared with rates in developed countries, the baseline rate of
CAUTI found in this study (13.07 per 1000 urinary catheter-days)
was 10-fold higher than that in the USA (1.5 CAUTI per 1000
urinary catheter-days determined by the CDC/NSHN18) and higher
than that found in the KISS study (2.5 CAUTI per 1000 urinary
catheter-days).19
In comparison with pooled CAUTI rates from developing
countries, our CAUTI baseline rate was higher than the rates
measured in the Fourth International INICC Report published in
2012 (6.3 CAUTIs per 1000 urinary catheter-days).6
As far as we know, there has been no single study addressing the
effectiveness of CAUTI prevention programs in Lebanon, and the
literature on this issue is extremely scant from developing
countries.1 In a previous study conducted in Lebanon in 1997,
CAUTI was the third most common nosocomial infection (18%).20
In a study in Saudi Arabia, the CAUTI rate was 11.4, which is similar
to our baseline rate of 13.07.21
In our study, patient characteristics, such as age, gender, device
use ratio, surgical stay, cancer, endocrine diseases, and abdominal
surgery conditions, as well as urinary catheter mean duration,
were similar and showed similar patient intrinsic risk in both study
phases.
During the implementation of the INICC multidimensional
approach, hand hygiene compliance remained high and wasTable 2
Catheter-associated urinary tract infection rates stratiﬁed by length of participation of th
(INICC); Poisson regression analysis
Months since joining INICC Urinary catheter
days, n
CAUTI, n 
1–3 months (baseline) 306 4 
4–12 months 1325 6 
Second year 2780 7 
Third year 2194 8 
Fourth year 3223 0 
CAUTI, catheter-associated urinary tract infection; ICU, intensive care unit; IRR, incidesimilar in both phases. Similarly, compliance rates with the correct
position of the urinary catheter (over thigh) and collection bag
hanging were 100% in both phases. A multivariate analysis
reviewed by Salgado et al. reported catheter care violations among
the ﬁve risk factors associated with the later development of a
CAUTI.22
During the study period, the high CAUTI rate at baseline was
reduced from 13.07 to 2.21 per 1000 urinary catheter-days,
showing an 83% CAUTI rate reduction and evidencing the
effectiveness of the applied multidimensional approach.
Regarding the microorganism proﬁle, we identiﬁed a predomi-
nance of Acinetobacter spp, Candida spp, and Escherichia coli during
the two periods; this is similar to the ﬁndings of other studies
conducted in Lebanon.23
This study has many limitations. First, our ﬁndings are not to be
generalized to all ICU patients in Lebanon. However, in this study it
was shown that a multidimensional approach is fundamental to
understanding and ﬁghting the occurrence of CAUTI in the ICU
setting in Lebanon. Second, the 3-month baseline period may have
been too short and might have led to an overestimation of the
effect of the intervention. Nevertheless, during the baseline period
the sample size was sufﬁcient and the conﬁdence intervals for the
baseline rate are narrow. In addition, this length of baseline period
is common in the scientiﬁc literature. Third, we did not count on
the necessary resources to collect more data on process surveil-
lance and measure compliance with all the elements included in
our bundle. Therefore, we could not evaluate the implications of
individual interventions or other contextual factors related to the
ICU or hospital. Speciﬁcally, we were not able to perform process
surveillance for the following bundle components: insertion of
urinary catheters only when needed and removal when unneces-
sary; use of indwelling urethral catheters for perioperative and for
selected surgical procedures; urine output monitoring in criticallye intensive care unit in the International Nosocomial Infection Control Consortium
Crude CAUTI rate/
1000 urinary-
catheter days
IRR accounting
for clustering
by ICU
p-Value
13.07 1.0 -
4.53 0.35 (0.1–1.23) 0.1
2.52 0.2 (0.056–0.66) 0.01
3.65 0.28 (0.84–0.92) 0.037
0.0 0 (-) 0.994
nce rate ratio.
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obstruction; assistance in pressure ulcer healing for incontinent
residents; to consider other methods for management, including
condom catheters or in-and-out catheterization, when appro-
priate; to use as small a catheter as possible; use of gloves, a
drape, and sponges; a sterile or antiseptic solution for cleaning
the urethral meatus; a single-use packet of sterile lubricant jelly
for insertion; to insert catheters by use of aseptic technique and
sterile equipment; to empty the collecting bag regularly; to
avoid allowing the draining spigot to touch the collecting
container; and on the cleaning of the meatal area as part of
routine hygiene. These data would greatly contribute to advance
our knowledge with regard to quality improvement in this
setting of a hospital in Lebanon and would provide an accurate
description of the successful results of our approach. Neverthe-
less, our main goal was to reduce the high baseline CAUTI rates
found in our ICUs, and although our interventions were
inexpensive, the individual evaluations would have required
more allocation of time, contributing to unnecessary harm for
ICU patients. Finally, we could not quantify in detail some of
the non-quantiﬁable interventions included in our approach,
such as education and training. Fortunately, as from January
2012, we have been able to collect all these process surveillance
data.
In conclusion, this study is the ﬁrst multicenter study to
report a substantial reduction in CAUTI rates in the ICU setting
of Lebanon, showing this kind of infection control approach to
be successful. Although the intrinsic risk in some patients was
higher during the intervention period, a multidimensional
approach including improved compliance with CAUTI preven-
tion measures resulted in signiﬁcant reductions in the CAUTI
incidence rate. Good as it is, it is worth highlighting that the
reduction in CAUTI rates does not derive from surveillance itself.
This systematically collected data should serve to guide
healthcare professionals in their strategies for improving patient
care practices, such as performance feedback, as demonstrated
in several previous studies conducted in resource-limited
countries.14
These preventive strategies found to be effective in the INICC
ICUs of Lebanon could promote a wider acceptance of infection
control programs in hospitals, leading to signiﬁcant CAUTI
reductions worldwide. Within the INICC network, investigators
are provided with training and methodological tools to perform
outcome and process surveillance, and to implement effective
infection prevention programs. Furthermore, the publication of
these ﬁndings contributes to the fostering of relevant scientiﬁc
evidence-based literature from developing countries. For this
reason, every hospital is invited to participate in the INICC project,
which was set up to respond to the compelling need in the
developing world to signiﬁcantly prevent, control, and reduce
CAUTIs and their adverse effects.
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